Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
10.35
+0.20 (1.97%)
At close: Nov 28, 2025, 1:00 PM EST
9.96
-0.39 (-3.77%)
After-hours: Nov 28, 2025, 4:56 PM EST
Clene Employees
As of December 31, 2024, Clene had 76 total employees, including 75 full-time and 1 part-time employees. The number of employees decreased by 9 or -10.59% compared to the previous year.
Employees
76
Change (1Y)
-9
Growth (1Y)
-10.59%
Revenue / Employee
$2,816
Profits / Employee
-$401,263
Market Cap
107.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 76 | -9 | -10.59% |
| Dec 31, 2023 | 85 | -1 | -1.16% |
| Dec 31, 2022 | 86 | -16 | -15.69% |
| Dec 31, 2021 | 102 | 28 | 37.84% |
| Dec 31, 2020 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Walmart | 2,100,000 |
| Costco Wholesale | 341,000 |
| PepsiCo | 319,000 |
| Anheuser-Busch InBev | 143,885 |
| Unilever | 120,040 |
| The Procter & Gamble Company | 109,000 |
| Mondelez International | 90,000 |
| Philip Morris International | 83,100 |
CLNN News
- 9 days ago - Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference - GlobeNewsWire
- 16 days ago - Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 5 weeks ago - Clene to Present at the Emerging Growth Conference - GlobeNewsWire
- 6 weeks ago - Clene to Participate in a Panel Discussion at the Maxim Growth Summit - GlobeNewsWire
- 2 months ago - Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients - GlobeNewsWire
- 3 months ago - Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson's Disease - GlobeNewsWire
- 3 months ago - Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights - GlobeNewsWire